Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • BAN: Private Sectors...

    BAN: Private Sectors wont be allowed to sell Detox Drug Buprenorphine in Punjab

    Farhat NasimWritten by Farhat Nasim Published On 2019-09-10T16:11:14+05:30  |  Updated On 10 Sept 2019 4:11 PM IST
    BAN: Private Sectors wont be allowed to sell Detox Drug Buprenorphine in Punjab

    Apart from this, the Government intends to allow psychiatric clinics to dispense buprenorphine and naloxone. It is also in the process of framing Punjab Registration and Regulation of Psychiatric Clinic Rules 2019.


    Chandigarh: In a move to regulate the misuse of popular detoxification drug buprenorphine, the Punjab Government is considering to revoke the right of dispensing the medicine by private rehabilitation centres and reserve the rights for providing the drug by the Government centres.


    The development comes following a proposal by the Punjab Food and Drug Administration (FDA), to restrict private centres to prescribe the medicine and allow only the government centres to dispense buprenorphine. The proposal was deliberated in a meeting held on September 6 by principal Health Secretary Anurag Agarwal along with commissioner food and drugs K S Pannu, joint director drugs Pradeep Mattu, owners of private de-addiction centres and psychiatrists.


    During the meeting, Agarwal expressed his dissatisfaction over private centres fleecing patients and even presented examples of private centres supplying buprenorphine in disproportionally high number. The concern was discussed in detail and all stakeholders were appraised about it.


    As per a recent media report in TOI, it has been concluded that all private psychiatrists will be allowed to prescribe the medicine which will be dispensed by Government centres while no privately run rehabilitation centres will be allowed to do the same. The ban, however, will come to force only when the government works out modalities for providing the medicine at controlled rates at these centres.


    Also Read: Pharma Drug Ban: HC gives next date of hearing as March 28


    After the modalities are worked out, only Government supplied quality and rate-controlled buprenorphine will be available at private centres at controlled rates. Moreover, the number of dispensing points will be raised up to 300 which is presently 181. This will ensure that patients face no difficulty.


    Apart from this, the Government intends to allow psychiatric clinics to dispense buprenorphine and naloxone. It is also in the process of framing Punjab Registration and Regulation of Psychiatric Clinic Rules 2019.


    Presently, Psychiatric clinics provide OPD-based psychiatric health facilities and are not allowed to dispense detoxification medicines. Taking undue advantage of the prevailing situation, many private centres allegedly profit by selling buprenorphine for around Rs 400 per strip. However, the same drug costs the government about Rs 50.


    Also Read: Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names


    In the government-run centres, patients are given a daily dose of medicine for free of cost while private centres do so for a week or more. Moreover, there is no check on the quality of medicine procured by private centres.


    The proposal has been lauded by Dr Rupinder Kapur, president of Punjab chapter of psychiatrists' association.


    "If everyone will have a level playing field, the maximum benefit will be of society. The move will bring more clinical autonomy to every psychiatrist," Dr Kapur told TOI.

    buprenorphinebuprenorphine bandetoxification drugFood and Drug Administrationgovernment health centresHealthcarenaloxoneprivate health centePsychiatric Clinic Rules 2019psychiatric drugPunjabpunjab govtPunjab Health Secretaryrhabilitation centrestate fda
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok